https://www.bloomberg.com/authors/AU5tuVUF1Us/rena-conti RSS for Node Wed, 13 May 2026 07:22:26 GMT https://www.bloomberg.com/view/articles/2020-08-13/how-to-study-generic-drugs-for-a-better-covid-19-treatment https://www.bloomberg.com/view/articles/2020-08-13/how-to-study-generic-drugs-for-a-better-covid-19-treatment Thu, 13 Aug 2020 10:30:25 GMT CAMBRIDGE, ENGLAND - MAY 21: Stella Burns, Lead Clinical Nurse Specialist prepares medication for a patient taking part in the TACTIC-R trial at Addenbrooke's hospital on May 21, 2020 in Cambridge, England. The new trial known as TACTIC-R is testing whether existing drugs will help prevent the body's immune system from overreacting, which scientists hope could prevent organ failure and death in COVID-19 patients. (Photo by Kirsty Wigglesworth-Pool/Getty Images)